MarketPulse
C

$CELU

1 article found
0 positive
0 negative
1 neutral
BenzingaBenzinga··Vandana Singh

NexGel to Triple Revenue With Celularity Biomaterial Portfolio Acquisition

NexGel acquires regenerative biomaterial portfolio from Celularity, expecting to nearly triple 2026 revenue to $35M and achieve immediate profitability.
NXGLNXGLWCELUCELUWacquisitionprofitability